0001824920 0001824920 2025-02-25 2025-02-25 0001824920 ionq:CommonStockParValue00001PerShareMember 2025-02-25 2025-02-25 0001824920 ionq:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShareMember 2025-02-25 2025-02-25

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K/A

(Amendment No. 1)

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 28, 2025 (February 25, 2025)

 

 

IonQ, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-39694   85-2992192
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

4505 Campus Drive

College Park, Maryland

  20740
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: 301 298-7997

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common stock, par value $0.0001 per share   IONQ   New York Stock Exchange
Warrants, each exercisable for one share of common stock for $11.50 per share   IONQ WS   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K filed by IonQ, Inc. (the “Company”) with the U.S. Securities and Exchange Commission on February 26, 2025 (the “Original Form 8-K”) filed to, among other things, report under Item 8.01 that the Company had entered into a definitive agreement to acquire a controlling stake of ID Quantique SA, a global leader in quantum networking and sensing, headquartered in Geneva, Switzerland, in an all-stock transaction for up to approximately 5.2 million shares of common stock of the Company (the “Transaction”). The purpose of this Amendment is to incorporate the information contained in Item 8.01 of the Original Form 8-K under Item 3.02 as well, to the extent required, and to provide supplemental information required by Item 3.02. Except as set forth herein, no other changes have been made to the Original Form 8-K, and Item 2.02, Item 5.02, Item 7.01, Item 8.01 and Item 9.01 of the Original Form 8-K are incorporated herein by reference.

 

Item 3.02

Unregistered Sales of Equity Securities

To the extent required by this Item 3.02, the information contained in Item 8.01 of the Original Form 8-K is incorporated herein by reference.

The shares of common stock issued at the closing of the Transaction will be restricted securities, and the issuance and sale of the shares will be exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D promulgated thereunder.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

No.

   Description
10.1*   

Offer Letter by and between the Company and Niccolo de Masi, dated February 26, 2025 (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-39694), filed with the SEC on February 26, 2025).

10.2*   

Performance-Based Award Grant Notice by and between the Company and Niccolo de Masi, dated February 26, 2024 (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-39694), filed with the SEC on February 26, 2025).

99.1   

Earnings Press Release, dated February 26, 2025 (incorporated herein by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K (File No. 001-39694), filed with the SEC on February 26, 2025).

99.2   

ID Quantique Press Release, dated February 26, 2025 (incorporated herein by reference to Exhibit 99.2 to the Company’s Current Report on Form 8-K (File No. 001-39694), filed with the SEC on February 26, 2025).

99.3   

Leadership Press Release, dated February 26, 2025 (incorporated herein by reference to Exhibit 99.3 to the Company’s Current Report on Form 8-K (File No. 001-39694), filed with the SEC on February 26, 2025).

99.4   

Board of Directors Press Release, dated February 26, 2025 (incorporated herein by reference to Exhibit 99.5 to the Company’s Current Report on Form 8-K (File No. 001-39694), filed with the SEC on February 26, 2025).

104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*

Portions of these Exhibits have been omitted in accordance with Regulation S-K Item 601(b)(10)(iv). The Registrant agrees to furnish a copy of an unredacted agreement to the SEC upon its request.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      IonQ, Inc.
Date: February 28, 2025     By:  

/s/ Stacey Giamalis

      Stacey Giamalis
      Chief Legal Officer and Corporate Secretary
v3.25.0.1
Document and Entity Information
Feb. 25, 2025
Document Information [Line Items]  
Document Type 8-K/A
Amendment Flag true
Document Period End Date Feb. 25, 2025
Entity Registrant Name IonQ, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-39694
Entity Tax Identification Number 85-2992192
Entity Address Address Line 1 4505 Campus Drive
Entity Address City Or Town College Park
Entity Address State Or Province MD
Entity Address Postal Zip Code 20740
City Area Code 301
Local Phone Number 298-7997
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Description This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K filed by IonQ, Inc. (the “Company”) with the U.S. Securities and Exchange Commission on February 26, 2025 (the “Original Form 8-K”) filed to, among other things, report under Item 8.01 that the Company had entered into a definitive agreement to acquire a controlling stake of ID Quantique SA, a global leader in quantum networking and sensing, headquartered in Geneva, Switzerland, in an all-stock transaction for up to approximately 5.2 million shares of common stock of the Company (the “Transaction”). The purpose of this Amendment is to incorporate the information contained in Item 8.01 of the Original Form 8-K under Item 3.02 as well, to the extent required, and to provide supplemental information required by Item 3.02. Except as set forth herein, no other changes have been made to the Original Form 8-K, and Item 2.02, Item 5.02, Item 7.01, Item 8.01 and Item 9.01 of the Original Form 8-K are incorporated herein by reference.
Entity Central Index Key 0001824920
Common Stock Par Value 0.0001 Per Share [Member]  
Document Information [Line Items]  
Security 12b Title Common stock, par value $0.0001 per share
Trading Symbol IONQ
Security Exchange Name NYSE
Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At An Exercise Price Of 11.50 Per Share [Member]  
Document Information [Line Items]  
Security 12b Title Warrants, each exercisable for one share of common stock for $11.50 per share
Trading Symbol IONQ WS
Security Exchange Name NYSE

IonQ (NYSE:IONQ)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse IonQ
IonQ (NYSE:IONQ)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse IonQ